David Batten Appointed as President of Skila

June 1, 2010 - PRLog -- Morris Plains, NJ, June 01, 2010 – Moish Tov, Chairman and CEO of Skila, is pleased to announce the appointment of David Batten to the newly created position of President. In this role, Batten will lead the organization's strategic planning, partnership and M&A initiatives. "I am pleased and excited to have David join our Executive leadership team and benefit from his experience and dedicated contributions towards the growth and future of our organization," says Tov.

Batten has an extensive background in finance, strategic development, and corporate growth. For the past decade, he has been involved with several early stage software and services companies servicing the life sciences and consumer sectors as an active board member and investor. He was a co-founder of Johnson-Grace Company, a pioneer in digital compression that was purchased by AOL and has served as Skila's Director and strategic advisor for over ten years. Batten also served as Managing Director at The First Boston Corporation in New York and an Executive Director of CSFB, Ltd. in London and was in charge of the Capital Markets Departments in both organizations. Subsequently, he was a General Partner of the Blackstone Group and of Lazard Freres & Co.

"While most companies face difficulties defining innovation and building a customer base in this challenging economy, we are fortunate that changes in the life sciences environment are truly bringing the market to Skila,” says Batten. “What encourages me most," continues Batten "is Skila's impressive sales pipeline and product suite, including the recently launched iKOL database that contains real-time identification and profiling capabilities for more than 2.5 million medical experts and institutions world-wide. "
Batten is a graduate of Williams College and the Stanford Graduate School of Business and an active sailor with over 30,000 ocean miles on his resume.

About Skila Skila is a global technology and services company specializing in knowledge and effectiveness solutions for the healthcare industry. Skila’s solutions address the broad needs of global marketing, medical, market access, executive and alliance management teams. These solutions include a unique methodology, robust technology and key continuous services for effectively managing global product launches, key opinion leader relationships, market access / managed care, business performance, competitive intelligence, and key partnerships and alliances.

Having developed strong relationships with a broad number of global Pharmaceutical companies, Skila’s solutions have been deployed in over 60 countries, supporting numerous global brands and over 10 million user interactions. Skila’s long-standing commitment and understanding of customers’ needs has resulted in the long-term growth and adoption of our methodology, technology and continuous services as the business platform of choice for many of our clients. To learn more about Skila, please visit our website at www.skila.com.